Liver carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
This study is to investigate the methylation status of multiple tumor suppressor 1 (p16), secreted glycoprotein 2 (SLIT2), scavenger receptor class A, member 5 putative (SCARA5), and human runt-related transcription factor 3 (Runx3) genes in the peripheral blood of hepatocellular carcinoma (HCC).This is a case-control study.
|
29019900 |
2017 |
Liver carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Large-scale data mining of the Oncomine database has revealed heterogeneous expression of Slit2 in HCC.
|
27176045 |
2016 |
Liver carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
Thus, SLIT2 may be useful as a therapeutic target in the treatment of HCC.
|
19100240 |
2009 |
Liver carcinoma
|
0.330 |
Biomarker
|
disease |
CTD_human |
Thus, SLIT2 may be useful as a therapeutic target in the treatment of HCC.
|
19100240 |
2009 |
Liver carcinoma
|
0.330 |
PosttranslationalModification
|
disease |
LHGDN |
Thus, SLIT2 may be useful as a therapeutic target in the treatment of HCC.
|
19100240 |
2009 |
Small cell carcinoma of lung
|
0.310 |
Biomarker
|
disease |
CTD_human |
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
|
22941188 |
2012 |
Epilepsy, Temporal Lobe
|
0.310 |
Biomarker
|
disease |
CTD_human |
Slit2 expression was significantly higher in TLE patients as compared with the controls.
|
20153733 |
2010 |
Epilepsy, Temporal Lobe
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Slit2 expression was significantly higher in TLE patients as compared with the controls.
|
20153733 |
2010 |
Small cell carcinoma of lung
|
0.310 |
PosttranslationalModification
|
disease |
BEFREE |
SLIT2 promoter methylation was detected in 59% of breast cancer, 77% of non-small cell lung cancer, and 55% of small cell lung cancer cell lines.
|
12384551 |
2002 |
Uncinate Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: A study of epileptic patients and experimental animals.
|
20153733 |
2010 |
Epilepsy, Benign Psychomotor, Childhood
|
0.300 |
Biomarker
|
disease |
CTD_human |
Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: A study of epileptic patients and experimental animals.
|
20153733 |
2010 |
Epilepsy, Lateral Temporal
|
0.300 |
Biomarker
|
disease |
CTD_human |
Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: A study of epileptic patients and experimental animals.
|
20153733 |
2010 |
Anti-Basement Membrane Glomerulonephritis
|
0.200 |
Biomarker
|
disease |
RGD |
Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis.
|
15215188 |
2004 |
Ciliary Motility Disorders
|
0.200 |
Biomarker
|
group |
MGD |
|
|
|
Kartagener Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Cystic kidney
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 2, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy, Visceral, 3, Autosomal
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 4, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 1, X-LINKED
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Heterotaxy Syndrome
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
HETEROTAXY, VISCERAL, 6, AUTOSOMAL
|
0.200 |
Biomarker
|
disease |
MGD |
|
|
|
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
SLIT2 can induce BC cell motility and chemotaxis, but the latter requires the presence of heparin.
|
30842157 |
2019 |
Fetal Membranes, Premature Rupture
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Risk of spontaneous preterm birth and fetal growth associates with fetal SLIT2.
|
31194736 |
2019 |